Your browser doesn't support javascript.
loading
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
Barilà, Gregorio; Grassi, Angela; Cheon, HeeJin; Teramo, Antonella; Calabretto, Giulia; Chahal, Jasmanet; Vicenzetto, Cristina; Almeida, Julia; Shemo, Bryna C; Shi, Min; Gasparini, Vanessa Rebecca; Munoz-Garcia, Noemi; Pastoret, Cédric; Nakazawa, Hideyuki; Oshimi, Kazuo; Sokol, Lubomir; Ishida, Fumihiro; Lamy, Thierry; Orfao, Alberto; Morice, William G; Loughran, Thomas P; Semenzato, Gianpietro; Zambello, Renato.
Afiliação
  • Barilà G; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Grassi A; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Cheon H; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
  • Teramo A; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA.
  • Calabretto G; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Chahal J; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Vicenzetto C; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Almeida J; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Shemo BC; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA.
  • Shi M; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Gasparini VR; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Munoz-Garcia N; Department of Medicine and Cytometry Service, Cancer Research Center (Institute of Molecular and Cell Biology of Cancer-Consejo Superior de Investigaciones Científicas/Universidad de Salamanca), University of Salamanca, Instituto de Investigación Biomédica de Salamanca and Centro de Investigación Bi
  • Pastoret C; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA.
  • Nakazawa H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, NY.
  • Oshimi K; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Sokol L; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Ishida F; Department of Medicine and Cytometry Service, Cancer Research Center (Institute of Molecular and Cell Biology of Cancer-Consejo Superior de Investigaciones Científicas/Universidad de Salamanca), University of Salamanca, Instituto de Investigación Biomédica de Salamanca and Centro de Investigación Bi
  • Lamy T; Department of Hematology, Rennes University Hospital, Rennes, France.
  • Orfao A; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
  • Morice WG; Department of Medicine, Division of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
  • Loughran TP; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.
  • Semenzato G; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
  • Zambello R; Department of Hematology, Rennes University Hospital, Rennes, France.
Blood ; 141(9): 1036-1046, 2023 03 02.
Article em En | MEDLINE | ID: mdl-36096473

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Granular Grande / Neutropenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Granular Grande / Neutropenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article